In vivo recovery and survival of red cells after photodynamic treatment with thiopyrylium and red light using a canine model

Vox Sanguinis

Volumn 92, Issue 2, 2007, Pages 157-159

  Skripchenko, A ^a,b   Balch, A ^c   Mackin, A ^c   Wagner, S J ^b  

^a AMERICAN RED CROSS   (United States)

^b HOLLAND LABORATORY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Canine red cell; In vivo survival; Pathogen reduction; Photosensitizer; Thiopyrylium

Indexed keywords

PHOTOSENSITIZING AGENT; THIOPYRYLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; IN VIVO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT;

ANILINE COMPOUNDS; ANIMALS; BACTERIAL INFECTIONS; BLOOD PRESERVATION; CELL SURVIVAL; DECONTAMINATION; DOGS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; MODELS, ANIMAL; PHOTOSENSITIZING AGENTS; PYRANS; VIRUS DISEASES;

EID: 33846933033     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00864.x     Document Type: Article

References (11)

1. Dodd RY, Notari EP, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42:975-979
2. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME; West Nile Virus Transmission Investigation Team: Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236-1245
3. Herwaldt BL, Neitzel DF, Gorlin JB, Jensen KA, Perry EH, Peglow WR, Slemenda SB, Won KY, Nace EK, Pieniazek NJ, Wilson M: Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion 2002; 42:1154-1158
4. Cimo PL, Luper WE, Scouros MA: Transfusion-associated Chagas' disease in Texass: report of a case. Tex Med 1993; 89:48-50
5. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT: Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341:1237-1239
6. Wagner SJ, Skripchenko A, Cincotta L, Thompson-Montgomery D, Awatefe H: Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage properties. Transfusion 2005; 45:752-760
7. Hogman CF, Eriksson L, Gong J, Hogman AB, Payrat JM: Shall red cells units stand upright, lie down or be mixed during storage? In vitro studies of red cells collected in 0.5 CPD and stored in RAS2 (Erythrosol). Transfus Sci 1995; 16:193-199
8. Brownlee L, Wardrop KJ, Sellon RK, Meyers KM: Use of prestorage leukoreduction filter effectively removes leukocytes from canine whole blood while preserving red blood cell viability. J Vet Intern Med 2000; 14:412-417
9. Wardrop KJ, Tucker RL, Anderson EP: Use of an in vitro biotinylation technique for determination of posttransfusion viability of stored canine packed red blood cells. Am J Vet Res 1998; 59:397-400
10. Price GS, Armstrong PJ, McLeod DA, Babineau CA, Metcalf MR, Sellett LC: Evaluation of citrate-phosphate-dextrose-adenine as a storage medium for packed canine erythrocytes. J Vet Intern Med 1988; 2:126-132
11. Rios JA, Hambleton J, Viele M, Rugg N, Sindermann G, Greenwalt T, Wages D, Cook D, Corash L: Viability of red cells prepared with S-303 pathogen inactivation treatment. Transfusion 2006; 46:1778-1786